TrialAntimicrobial agents and chemotherapy2011

Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects.

David E Geller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.